Lu, M.-D.; Li, H.; Nie, J.-H.; Li, S.; Ye, H.-S.; Li, T.-T.; Wu, M.-L.; Liu, J.
Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations. Int. J. Mol. Sci. 2022, 23, 14385.
https://doi.org/10.3390/ijms232214385
AMA Style
Lu M-D, Li H, Nie J-H, Li S, Ye H-S, Li T-T, Wu M-L, Liu J.
Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations. International Journal of Molecular Sciences. 2022; 23(22):14385.
https://doi.org/10.3390/ijms232214385
Chicago/Turabian Style
Lu, Meng-Di, Hong Li, Jun-Hua Nie, Sheng Li, Hai-Shan Ye, Ting-Ting Li, Mo-Li Wu, and Jia Liu.
2022. "Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations" International Journal of Molecular Sciences 23, no. 22: 14385.
https://doi.org/10.3390/ijms232214385
APA Style
Lu, M.-D., Li, H., Nie, J.-H., Li, S., Ye, H.-S., Li, T.-T., Wu, M.-L., & Liu, J.
(2022). Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations. International Journal of Molecular Sciences, 23(22), 14385.
https://doi.org/10.3390/ijms232214385